Cite

HARVARD Citation

    Chen, S. et al. (2020). Selective targeting of PI3Kδ suppresses human IL-17-producing T cells and innate-like lymphocytes and may be therapeutic for IL-17-mediated diseases. Journal of autoimmunity. p. . [Online]. 
  
Back to record